Compare Morgan Stanley (MS) vs Procter & Gamble Co (PG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Morgan Stanley vs Procter & Gamble Co — how do they compare? Morgan Stanley trades at $215.19 (market cap $338.50B), while Procter & Gamble Co trades at $146.14 (market cap $340.39B). The key difference: Morgan Stanley and Procter & Gamble Co are close in size by market cap, and Procter & Gamble Co pays the higher dividend (2.97%). Which is the better fit depends on your goals.
| MS | PG | |
|---|---|---|
Market Cap | $338.50B | $340.39B |
Sector | Financials | Consumer Staples |
52-Week High | $228.42 | $167.18 |
52-Week Low | $143.88 | $138.10 |
Dividend Yield | 2.14% | 2.97% |
Volume | — | 6,423,436 |
Enterprise Value | — | $366.23B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Morgan Stanley (MS) trades at $216.26, up 1.18% with a bullish technical outlook and strong earnings beats in recent quarters. Revenue grew to $66.0B in 2025, with net income margin expanding to 25.56%. The stock is supported by analyst consensus price target of $239.58 and recent news of leading Anthropic's IPO, indicating robust business momentum.
Outlook remains positive given earnings growth and institutional support, but risks include volatile cash flows and high debt levels. The stock offers upside to consensus targets, though investors should monitor interest expense impacts and market volatility.
Procter & Gamble (PG) trades at $145.21, down 0.38% on the day, with a bearish technical signal from moving averages. The company maintains strong fundamentals with consistent earnings beats, including Q2 2026 EPS of $1.43 beating expectations of $1.41. Revenue reached $84.28 billion in 2025 with net income of $15.97 billion, supported by a robust 18.44% net margin and 30.13% ROE. Recent developments include a new WNBA partnership and a $1.09 dividend declaration for August 2026 payment.
PG offers stable dividend income with 69 consecutive years of increases, but faces premium valuation concerns at 22.12 P/E ratio. Analyst consensus targets $161.20 with 53% buy ratings, suggesting 11% upside potential. Key risks include soft demand outlook and elevated valuation multiples compared to peers. The stock presents a defensive investment opportunity amid market volatility, though near-term growth appears modest.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Read more on MS →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
